Hearing may be end of road for breast cancer drug
Monday, June 27, 2011 - 10:31
in Health & Medicine
(AP) -- The best-selling cancer drug in the world comes under federal scrutiny once again this week, as drugmaker Roche makes a last-ditch effort to keep Avastin approved for breast cancer, despite evidence that it is ineffective against the disease.